Dextromethorphan Abuse "Not Gaining Popularity," Whitehall-Robins Says
This article was originally published in The Tan Sheet
Executive Summary
Misuse of the cough suppressant dextromethorphan hydrobromide is "limited and episodic" and is "not gaining popularity," Whitehall-Robins tells FDA in a Jan. 19 submission. The firm's letter and attached materials relate to a MedWatch adverse event report detailing the Oct. 13 death of a 23-year-old man who "committed suicide by hanging after probably having ingested a DM-containing product."
You may also be interested in...
National Survey Results Add To DXM Abuse Concerns; CHPA Touts Education
Results from a national survey of illicit drug use by students provide a platform to address the problem of young people abusing over-the-counter cough and cold medicines containing dextromethorphan, the Consumer Healthcare Products Association said Dec. 21
National Survey Results Add To DXM Abuse Concerns; CHPA Touts Education
Results from a national survey of illicit drug use by students provide a platform to address the problem of young people abusing over-the-counter cough and cold medicines containing dextromethorphan, the Consumer Healthcare Products Association said Dec. 21
National Survey Results Add To DXM Abuse Concerns; CHPA Touts Education
Results from a national survey of illicit drug use by students provide a platform to address the problem of young people abusing over-the-counter cough and cold medicines containing dextromethorphan, the Consumer Healthcare Products Association said Dec. 21